Clinical Data And Patient Reported Outcome Data Of A Monofocal Iol With Enhanced Intermediate Function In Patients With Cataract In The Real World.

To evaluate clinical data after implantation of a monofocal + IOL, optimizing intermediate vision and patients satisfaction.

AugenCentrum und Augenkinik Rosenheim, Deutschland

Adult patients selected for cataract surgery with no need or request for IOL with toric or multifocal function were selected. 90 patients were bilateral and 38 were monolateral operated. The monofocal+ IOL (ICB800 Johnson & Johnson) was regarded as standard monofokal IOL and no additional information of the IOL was done. Inclusion criteria were cataract, exclusion criteria where nAMD. Optimization of intermediate and/or near visual acuity with minimonovision (-0,75) or monovision (-1,25 to -2,50 dpt) was intended, also considering ATR astigmatism. Thus the predicted refraction was not aimed to result in uncorrected distance acuity. Control of refraction and visual acuity was performed at month 1 post surgery. 

Out of 128 patients 218 eyes were implanted with the enhanced monofocal IOL (ZCB800). Mean predicted refraction was -0,05 (range 1,00 to -1,25). Mean cylinder -0,70 (range 0 to -2,25). UDVA was 0,89 (range 1,25 to 0,30), UIVA was 0,71 (range 1,20 to 0,40), UNVA was 0,65 (range 1,20 to 0,30) all in Snellen. Patients questionnaire was focussed on need of spectacles (numbers): fare distance: never/seldom 87 %, reading glasses: 43 %, PC monitor: never/seldom 49 % smartphone: never/seldom 62 %. 98 % of the patients had no or mild problems with the outcome in respect to spectacle independence.

These data represent no clinical trail but reallife data. The aim was to optimize spectacle independence also for patients with ocular comorbidities and without extra reembursent by the patient. The enhanced monofocal IOL helps reducing chair time and increases patient statisfaction.